Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2

Saved in:
Bibliographic Details
Published in:Blood and Lymphatic Cancer : Targets and Therapy
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552785578950656
collection WordPress RSS
FRELIP Feed Integration
container_title Blood and Lymphatic Cancer : Targets and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61064
institution FRELIP
journal_source_facet Blood and Lymphatic Cancer : Targets and Therapy
last_indexed 2026-06-20T21:26:07.255Z
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2
title_alt Alantolactona inhibe el linfoma de doble expresión mediante la glucógeno sintasa quinasa 3 beta y BCL2 como dianas duales
L'alantolactone inhibe le lymphome à double expression via la glycogène synthase kinase 3 bêta et le B-cell lymphoma 2 ciblés en double
Alantolactona inibe o linfoma de dupla expressão via glicogênio sintase quinase 3 beta e linfoma de células B2 com duplo alvo
title_auth Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2
title_es_txt Alantolactona inhibe el linfoma de doble expresión mediante la glucógeno sintasa quinasa 3 beta y BCL2 como dianas duales
title_fr_txt L'alantolactone inhibe le lymphome à double expression via la glycogène synthase kinase 3 bêta et le B-cell lymphoma 2 ciblés en double
title_full Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2
title_fullStr Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2
title_full_unstemmed Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2
title_pt_txt Alantolactona inibe o linfoma de dupla expressão via glicogênio sintase quinase 3 beta e linfoma de células B2 com duplo alvo
title_short Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2
title_sort alantolactone inhibits double expression lymphoma via dual-targeted glycogen synthase kinase 3 beta and b-cell lymphoma2
topic Oncology
General
Oncology
url https://www.dovepress.com/alantolactone-inhibits-double-expression-lymphoma-via-dual-targeted-gl-peer-reviewed-fulltext-article-BLCTT